内页banner
胡学达

联系方式

办公地点
京津医药谷高校成果转化基地22号楼北京大学京津冀生物医学前沿创新中心

胡学达

BTH-BIOPIC副主任

个人履历

2021.1-至今 北京百奥智汇有限公司 副总裁/副研究员 

2017.9-2020.12,北京大学,北京大学生物医学前沿创新中心,助理研究员 

2012.4-2017.8,中国医学科学院肿瘤医院/肿瘤研究所,助理研究员 

2006.9-2012.3,中国科学院北京基因组研究所,基因组学,博士

主要研究方向

长期从事肿瘤基因组学研究和肿瘤单细胞组学研究,参与发表49篇SCI论文,包括以主要作者发表Science、Nature Genetics、Cancer Cell等,系统刻画肿瘤免疫微环境的组成、状态和谱系。兼具学术和产业背景,曾在北京大学张泽民院士实验室做co-PI,后作为创始团队成员参与创办北京百奥智汇科技有限公司任职公司副总裁。

获奖及荣誉

2021,北京市自然科学一等奖 

2023,一种以非疾病诊断或治疗为目的的非小细胞肺癌 PD-1 免疫治疗响应预测方法(202310326560.5),发明专利,实审阶段

代表性论文及论著

1. Gui Y#, Guo G#, Huang Y#, Hu X#, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, He M, Li Z, Sun X, Jia W, Chen J, Yang S, Zhou F, Zhao X, Wan S, Ye R, Liang C, Liu Z, Huang P, Liu C, Jiang H, Wang Y, Zheng H, Sun L, Liu X, Jiang Z, Feng D, Chen J, Wu S, Zou J, Zhang Z, Yang R, Zhao J, Xu C, Yin W, Guan Z, Ye J, Zhang H, Li J, Kristiansen K, Nickerson ML, Theodorescu D, Li Y, Zhang X, Li S, Wang J, Yang H, Wang J, Cai Z. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet. 2011, 7;43(9):875-8.

2. Guo G#, Gui Y#, Gao S#, Tang A#, Hu X#, Huang Y, Jia W, Li Z, He M, Sun L, Song P, Sun X, Zhao X, Yang S, Liang C, Wan S, Zhou F, Chen C, Zhu J, Li X, Jian M, Zhou L, Ye R, Huang P, Chen J, Jiang T, Liu X, Wang Y, Zou J, Jiang Z, Wu R, Wu S, Fan F, Zhang Z, Liu L, Yang R, Liu X, Wu H, Yin W, Zhao X, Liu Y, Peng H, Jiang B, Feng Q, Li C, Xie J, Lu J, Kristiansen K, Li Y, Zhang X, Li S, Wang J, Yang H, Cai Z, Wang J. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet. 2011, 4;44(1):17-9.

3. Hu X, Zhang Z. Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches. Trends Genet. 2016, 32(2):127-37.

4. Tang Z, Li C, Zhang K, Yang M, Hu X. GE-mini: a mobile APP for large-scale gene expression visualization. Bioinformatics. 2017, 33(6):941-943.

5. Zhang F, Bai H, Gao R, Fei K, Duan J, Zhang Z, Wang J, Hu X. Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer. Cancer Immunol Immunother. 2020, 69(12):2599-2611.

6. Rao M, Wang X, Guo G, Wang L, Chen S, Yin P, Chen K, Chen L, Zhang Z, Chen X, Hu X*, Hu S*, Song J*. Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level. Basic Res Cardiol. 2021, 116(1):55.  

7. Zhang Y#, Chen H#, Mo H#, Hu X#, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, Wang Y, Chang Q, Gong T, Guan X, Hu T, Qian T, Xu B, Ma F, Zhang Z, Liu Z. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell. 2021, 5:S1535-6108(21)00499-2.

8. Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, Ren X, Wang L, Wu X, Zhang J, Wu N, Zhang N, Zheng H, Ouyang H, Chen K, Bu Z*, Hu X*, Ji J*, Zhang Z*. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021, 374(6574):abe6474.

9. Liu B#, Hu X#, Feng K#, Gao R, Xue Z, Zhang S, Zhang Y, Corse E, Hu Y, Han W, Zhang Z. Temporal single cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer. 2022, 3(1):108-121.

10. Jing Nie#*, Chunmeng Wang#, Liangtao Zheng#, Yang Liu, Chengcheng Wang, Yixin Chang, Yudi Hu, Bing Guo, Yuting Pan, Qingming Yang, Xueda Hu*, Weidong Han*. Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma. Blood. 2024, 144(18):1936-1950.

11. 胡学达,杨焕明,赫捷,吕有勇. 肿瘤基因组学与全球肿瘤基因组计划. 科学通报. 2015, 60 (09).